Rgenta Therapeutics Inc.

📍 Woburn, United States🗓 Founded 2020👥 30 employees💰 Last funded 2022
Biotechnology Research🌐 rgentatx.com
Website LinkedIn
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Our lead programs and unique approach are unlocking the therapeutic potential of historically undruggable targets in human diseases.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
China
1
Frequently asked questions
Who invested in Rgenta Therapeutics Inc.?
Rgenta Therapeutics Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Rgenta Therapeutics Inc. last raise funding?
The most recent investment in Rgenta Therapeutics Inc. recorded on gritt.io was in 2022.
When was Rgenta Therapeutics Inc. founded?
Rgenta Therapeutics Inc. was founded in 2020.
What industry is Rgenta Therapeutics Inc. in?
Rgenta Therapeutics Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Rgenta Therapeutics Inc. based?
Rgenta Therapeutics Inc. is headquartered in Woburn, United States.